Literature DB >> 30594604

Motives for using Kratom (Mitragyna speciosa Korth.) among regular users in Malaysia.

Darshan Singh1, Suresh Narayanan2, Christian P Müller3, Marc T Swogger4, Nelson Jeng Yeou Chear5, Eshal Bin Dzulkapli5, Nur Sabrina Mohd Yusoff5, Dinesh Sangarran Ramachandram5, Francisco León6, Christopher R McCurdy6, Balasingam Vicknasingam5.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: The leaves of Mitragyna speciosa (Korth.) or kratom have been traditionally used in Malaysia and Thailand mainly to enhance work productivity, as a folk remedy for treating common ailments, and as a mood enhancer. AIM OF THE STUDY: This present study sought to investigate kratom use motives among regular kratom users in Malaysia.
MATERIALS AND METHODS: A total of 116 regular kratom users were recruited for this cross-sectional survey. The Drinking Motives Questionnaire (DMQ) was administered to measure kratom use motives.
RESULTS: Our results indicate that heavy (>3 glasses daily, each glass contains 48.24-50.4 mg of mitragynine) kratom use was associated with coping (t87.09 =3.544, p < 0.001), and enhancement (t114 =2.180, p = 003). Single subjects had higher mean scores on the coping domain, relative to married subject (t113.89 =3.029, p < 0.003), while those earning more than RM1500 per month had higher mean scores on the enhancement domain, compare to those earning less than RM1500 per month (t107 =2.151, p < 0.034). Higher scores on the coping domain was significantly associated with higher (>3 glasses daily) kratom consumption (p < 0.0045).
CONCLUSIONS: Coping was associated with high (>3 glasses daily) kratom consumption among regular kratom users in traditional, rural settings.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Coping; Kratom; Malaysia; Motives; mitragynine and opioid

Mesh:

Substances:

Year:  2018        PMID: 30594604     DOI: 10.1016/j.jep.2018.12.038

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  13 in total

1.  Predicted Mode of Binding to and Allosteric Modulation of the μ-Opioid Receptor by Kratom's Alkaloids with Reported Antinociception In Vivo.

Authors:  Yuchen Zhou; Steven Ramsey; Davide Provasi; Amal El Daibani; Kevin Appourchaux; Soumen Chakraborty; Abhijeet Kapoor; Tao Che; Susruta Majumdar; Marta Filizola
Journal:  Biochemistry       Date:  2020-12-04       Impact factor: 3.162

2.  Physiological dependence to mitragynine indicated by a rapid cross-dependence procedure with heroin-dependent mice.

Authors:  Kai Yue; Jonathan L Katz; Xiji Shu
Journal:  Psychopharmacology (Berl)       Date:  2022-02-02       Impact factor: 4.530

3.  Mitragynine improves cognitive performance in morphine-withdrawn rats.

Authors:  Chiek Yi You; Zurina Hassan; Christian P Müller; Farah Wahida Suhaimi
Journal:  Psychopharmacology (Berl)       Date:  2021-10-25       Impact factor: 4.530

4.  Kratom instrumentalization for severe pain self-treatment resulting in addiction - A case report of acute and chronic subjective effects.

Authors:  Elisabeth Müller; Thomas Hillemacher; Christian P Müller
Journal:  Heliyon       Date:  2020-07-21

Review 5.  Mitragyna speciosa: Clinical, Toxicological Aspects and Analysis in Biological and Non-Biological Samples.

Authors:  Vânia Meireles; Tiago Rosado; Mário Barroso; Sofia Soares; Joana Gonçalves; Ângelo Luís; Débora Caramelo; Ana Y Simão; Nicolás Fernández; Ana Paula Duarte; Eugenia Gallardo
Journal:  Medicines (Basel)       Date:  2019-03-04

Review 6.  Kratom-Pharmacology, Clinical Implications, and Outlook: A Comprehensive Review.

Authors:  Steven C Eastlack; Elyse M Cornett; Alan D Kaye
Journal:  Pain Ther       Date:  2020-01-28

7.  Current and Future Potential Impact of COVID-19 on Kratom (Mitragyna speciosa Korth.) Supply and Use.

Authors:  Darshan Singh; Paula N Brown; Eduardo Cinosi; Ornella Corazza; Jack E Henningfield; Albert Garcia-Romeu; Christopher R McCurdy; Lance R McMahon; Walter C Prozialeck; Kirsten E Smith; Marc T Swogger; Charles Veltri; Zach Walsh; Oliver Grundmann
Journal:  Front Psychiatry       Date:  2020-11-26       Impact factor: 4.157

8.  Can Kratom (Mitragyna speciosa) Alleviate COVID-19 Pain? A Case Study.

Authors:  Antonio Metastasio; Elisabeth Prevete; Darshan Singh; Oliver Grundmann; Walter C Prozialeck; Charles Veltri; Giuseppe Bersani; Ornella Corazza
Journal:  Front Psychiatry       Date:  2020-11-19       Impact factor: 4.157

9.  Kratom use for depression/anxiety self-management: challenges during the COVID-19 pandemic - A case report.

Authors:  Elisabeth Müller; Thomas Hillemacher; Christian P Müller
Journal:  Heliyon       Date:  2021-05-10

10.  Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use.

Authors:  Kirsten E Smith; Jeffrey M Rogers; Destiny Schriefer; Oliver Grundmann
Journal:  Drug Alcohol Depend       Date:  2021-06-25       Impact factor: 4.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.